首页 › 基金 › Logos Global Management LP › MLYS

Logos Global Management LP 对 MLYS 的持仓历史

MINERALYS THERAPEUTICS INC · 医疗保健

Logos Global Management LP 在 Q2 2026 的 13F 申报中披露持有 MLYS(MINERALYS THERAPEUTICS INC)1,050,000 股,市值约 US$28.3M,约占其申报组合的 1.22%,在其申报持仓中市值排名第 26 位。 Logos Global Management LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.05M 股
申报持仓市值$28.33M
组合权重1.22%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Logos Global Management LP 对 MLYS 的持仓演变

Logos Global Management LP 于 Q2 2026 首次披露 MLYS 持仓:1,050,000 股(约 US$28.3M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.05M $28.33M 新进

关于 MLYS 与 13F 数据

MLYS(MINERALYS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 MLYS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MLYS 的基金

查看 MLYS 的全部基金持有人 →

常见问题

How long has Logos Global Management LP held MLYS?

Logos Global Management LP has disclosed MLYS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Logos Global Management LP's current position in MLYS?

As of Q2 2026, Logos Global Management LP holds 1.05M shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $28.33M, representing 1.22% of its reported portfolio and ranking #26.

Has Logos Global Management LP been buying or selling MLYS?

In the latest 13F filing (Q2 2026), Logos Global Management LP newly opened its position in MLYS.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.